HIF1A and cancer: A variety of HIF inhibitors have been developed for cancer therapy: for example, PX-748, 2ME2, TAT-cyclo-CLLFVY are HIF-1α inhibitors 13-15, and TC-S 7009 is HIF-2α inhibitors 16.